E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with B
>
Issuers starting with B, BK only
>
All stories on BioReliance Corp.
>
Stories on BioReliance Corp., BK only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
BioReliance Corp.
1/9/2012
BK
S&P: BioReliance unaffected
5/13/2011
BK
Moody's ups BioReliance loan
9/30/2010
BK
S&P cuts BioReliance loan
6/17/2010
BK
Moody's: BioReliance view up to stable
6/15/2009
BK
Moody's lowers BioReliance
4/12/2007
BK
Market Commentary:
Kinder, Dresser, Smart & Final, RGIS, Venoco, Local TV, Iconix, White Birch set talk; Carestream breaks
3/26/2007
BK
Moody's rates BioReliance loans B1, Caa1
3/26/2007
BK
S&P rates BioReliance B+, loans B+, B-
3/8/2007
BK
Market Commentary:
Celanese, BioReliance set talk; Building Materials, NSG tweak deals; Key Safety breaks
3/5/2007
BK
BioReliance to launch $155 million credit facility on Thursday
2/13/2007
BK
BioReliance to get new debt financing via UBS for buyout by Avista
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
